PPP Round II

Yesterday evening, the House passed a $484 billion supplement to the CARES Act, including $321 billion in fresh funds for small businesses through the Paycheck Protection Program.

Read More
Sean Steigerwald
PPP Funds Run Out

Yesterday at 10:30 am ET the $349 billion PPP bailout fund for small businesses ran out of funds. New applications aren’t being accepted by the Small Business Administration, unless and until congressional Democrats and Republicans settle their differences and pass a $250 billion expansion. The funds didn't even last two weeks.

Read More
Sean Steigerwald
The Economic Injury Disaster Loan

The CARES Act also expanded the Small Business Administration’s long-standing Economic Injury Disaster Loan Program (EIDL). The EIDL program was created to assist businesses, renters, and homeowners located in regions affected by declared disasters.

Read More
Sean Steigerwald
The Paycheck Protection Program

Today's the first day for small business to apply for the new Small Business Association's Payroll Protection Program. As you might expect, rolling out the largest stimulus package in the history of the US in 2 weeks is not going smoothly. 

Read More
Sean Steigerwald
Letgo to OfferUp

OfferUp, a Bellevue, Wash.-based peer-to-peer marketplace for local goods, agreed to buy New York-based rival Letgoin an all-stock deal. It also raised $120 million of new funding led by Letgo majority investor OLX Group (the classifieds unit of Naspers), which will hold a 40% stake in the combined company.

Read More
Sean Steigerwald
Clear waters

The COVID-19 pandemic has crippled Italy and is ricocheting its way around the globe. But amid the fear and sickness, Italy’s country-wide quarantine has had at least one uplifting consequence: Venice’s usually dark, murky waterways have turned noticeably more clear. 

Read More
Sean Steigerwald
Impossible Foods

Impossible Foods, a Redwood City, Calif.-based maker of plant-based protein products, raised $500 million in Series F funding led by Mirae Asset Global Investments.

Read More
Sean Steigerwald
Moderna Vaccine

The first U.S. clinical trial for a novel coronavirus vaccine began this week, based on a formulation selected by Moderna Therapeutics and the National Institute of Allergy and Infectious Diseases (NIAID).

Read More
Sean Steigerwald
Free money

Sequoia Capital has, for the first time in its history, parted ways with a newly funded company over a purported conflict of interest and, almost more shockingly, handed back its board seat, its information rights, its shares, and its full investment.

Read More
Sean Steigerwald